Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis

Patients with multiple myeloma (MM) treated with conventional chemotherapy have an average survival of approximately three years. High dose chemotherapy followed by autologous stem cell transplantation (ASCT), first introduced in the mid-1980s, is now considered the standard therapy for almost all p...

Full description

Bibliographic Details
Main Authors: Anna Dmoszynska, Ewa Wasik-Szczepanek, Adam Walter-Croneck, Joanna Manko, Magdalena Malek, Wojciech Legiec, Dariusz Jawniak, Marek Hus, Maria Cioch, Malgorzata Wach
Format: Article
Language:English
Published: Via Medica 2011-07-01
Series:Folia Histochemica et Cytobiologica
Subjects:
multiple myeloma
high dose chemotherapy
autologous peripheral blood stem cell transplantation
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/4120

Internet

http://czasopisma.viamedica.pl/fhc/article/view/4120

Similar Items